We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 1,025

Another diagnostic patent falls under 101
  • Foley & Lardner LLP
  • USA
  • April 10 2016

In Genetic Techs Ltd v Merial LLC (Fed. Cir., April 8, 2016), the Federal Circuit invalidated yet another diagnostic patent for failing to satisfy 35


Guarding Against Conclusory Statements & Why It Matters Even More Under The New PTAB Rules
  • Foley & Lardner LLP
  • USA
  • April 7 2016

A common deficiency highlighted in recent PTAB decisions denying institution of an IPR petition is that an expert declaration offers only


Amgen Hedges Its Bets With Cross-Petition For Certiorari Of Biosimilar Decision
  • Foley & Lardner LLP
  • USA
  • April 7 2016

Although Amgen originally did not petition the Supreme Court for certiorari to review the first Federal Circuit decision interpreting the BPCIA


What "Reasonably" Could Have Been Raised in an Inter Partes Review?
  • Foley & Lardner LLP
  • USA
  • April 6 2016

Since their introduction, inter partes review ("IPR") proceedings have had a close association with district court litigation. Indeed, litigation


The New AIA Rules May Help Patent Owners Avoid Trial
  • Foley & Lardner LLP
  • USA
  • April 5 2016

On May 2, 2016, the amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board (USPTO) go into effect, and apply


Will the Federal Circuit Invalidate 13,500 Continuation Patents?
  • Foley & Lardner LLP
  • USA
  • April 5 2016

The Federal Circuit is set to hear oral arguments in Immersion Corp. v. HTC Corp. on May 6, 2016. According to the amicus brief filed on behalf of


The USPTO Patent Quality Checklist
  • Foley & Lardner LLP
  • USA
  • March 31 2016

In furtherance of its efforts to improve patent quality, the USPTO has issued a request for comments on new patent quality metrics being developed for


Patent Venue Legislation Could Have A Dramatic Impact on Popular Patent Venues
  • Foley & Lardner LLP
  • USA
  • March 31 2016

This month, three United States Senators introduced the "Venue Equity and Non-Uniformity Elimination Act of 2016." The bill would dramatically narrow


USPTO Releases New Rules For AIA Post-Grant Proceedings
  • Foley & Lardner LLP
  • USA
  • March 31 2016

Today the USPTO released its long-awaited package of rules for AIA post-grant proceedings. The final rules largely track the proposed rules (see


Second Time Is The Charm For Kyle Bass Challenges Of Ampyra Patents
  • Foley & Lardner LLP
  • USA
  • March 29 2016

The USPTO Patent Trial and Appeal Board (PTAB) has decided to institute inter partes review (IPR) proceedings against the Ampyra patents based on the